Overview

Remifentanil and Nitroprusside for Controlled Hypotension

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is the comparison of the cardiovascular effects of remifentanil and nitroprusside for controlled hypotension
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Jeju National University School of Medicine
Treatments:
Nitroprusside
Remifentanil
Criteria
Inclusion Criteria:

- Patients who underwent endoscopic sinus surgery

Exclusion Criteria:

- patient who took any drug to influence this study

- patient with cardiovascular disease, renal disease or liver disease